OGT and Cognitive impairment: Decreased expression of OGT and lowered O-GlcNAc levels have been found to be linked to certain cognitive disorders (14), while elevated expression of OGT and increased O-GlcNAc levels are often associated with metabolic diseases including cancer (10).